Locations:
SearchXR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone.
By refining and expanding upon intellectual property initially developed at Cleveland Clinic, MediView technologies combine the power of augmented reality, telecollaboration and evidence-based insights. MediView XR, Inc. recently announced it has received FDA clearance for its XR90 augmented reality-based surgical visualization and navigation platform.
The device combines CT imaging with live ultrasound to perform minimally invasive procedures with enhanced precision, providing clinicians with 3D “X-ray vision” during procedures. The XR90 platform also offers visual information and reference to clinicians for analysis of procedural options during pre-operative planning, to help facilitate workflow, and to provide enhanced ergonomics to the user for heads-up, intra-operative display of medical images during ultrasound-guided needle procedures.
With the FDA 510(k) clearance, MediView has become the first company to achieve clearance for an augmented reality device utilizing live imaging combined with 3D XR visualization for pre- and intra-operative indications for use.
Press Release via PRNewswire
CLEVELAND, July 20, 2023 /PRNewswire/ — MediView XR, Inc., a leading clinical augmented reality med-tech company, announced today it received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) for its XR90 augmented reality-based surgical visualization and navigation platform. XR90 is intended to be used adjunctively for minimally invasive ultrasound and CT-guided needle-based procedures for soft tissue and bone. “This is not only the first 510(k) clearance for MediView, but it is the first 510(k) clearance for an augmented reality device utilizing live imaging combined with 3D XR visualization for pre- and intra-operative indications for use, which sets the stage for further advancements in augmented reality in the healthcare space.” said Adam Cargill, Director of Quality, Regulatory and Clinical Affairs at MediView.
“MediView is excited to receive 510(k) clearance for our XR90 platform and appreciate the team’s efforts and FDA’s partnership in achieving this milestone. We are in a new era of visualization, collaboration, and data insights in healthcare that can create patient, clinician and financial benefits,” said Mina Fahim, President and CEO of MediView. “XR90 expands the MediView portfolio of solutions available to practitioners as they look to simplify, democratize, and inform care delivery with the ultimate goal of improving and expanding access to the best care. Thank you to our employees, investors, and partners for making this possible. We are just at the beginning of a journey seeing the clinical adoption of game-changing data and digital healthcare solutions.”
MediView is utilizing augmented reality to address the long-standing limitations of current medical imaging technologies. Flat panel monitors limit practitioners to 2D imaging and require them to look away from the patient’s procedural site, disrupting hand-eye-coordination, resulting in reduced clinician confidence and potentially impacting outcomes. Through Microsoft’s Hololens2 AR headset, clinicians are able to visualize the patient’s ultrasound, as well as displays of other procedural information to facilitate their workflow. XR90 overcomes the limitations of two-dimensional imaging by providing physicians with 3D “X-Ray vision” during procedures – the ability to visualize a patient’s comprehensive internal anatomy in 3D underneath their skin, including bone, tissue, organs and vasculature. The device projects 3D virtual models of the patient’s own anatomy based on their CT imaging and combines that CT with live ultrasound to perform minimally invasive procedures, such as biopsies and tumor ablations (the use of heat or cold to kill cancerous tumors). XR90’s augmented reality capabilities include a Holographic Light Ray that tracks and displays the path of the physician’s instrument, CT-based 3D holographic anatomy display, and live ultrasound that is projected and displayed anatomically into the patient as the clinician scans, similar to a flashlight beam. The system is designed to provide visual information and reference to clinicians for analysis of procedural options during pre-operative planning, to help facilitate workflow, and to provide enhanced ergonomics to the user for heads-up, intra-operative display of medical images during ultrasound-guided needle procedures. XR90 is indicated to be used adjunctively to standard of care imaging.
XR90 is a diverse imaging tool providing a new way to view patient anatomy and visualize instrumentation pathway while maintaining natural alignment of senses. Clinicians at remote locations can also collaborate real-time with shared visualization, communication, and the ability to provide guidance during procedures for collaborative patient care. These features can provide increased support for understaffed facilities, rural or underserved populations and a distinct ability to limit caregiver and patient exposure to COVID-19 while maintaining care levels.
Recently, MediView announced that it had secured a $15M strategic funding round with backing from leading collaborators across clinical, industry and government, including Mayo Clinic, Cleveland Clinic, GE HealthCare, JobsOhio Capital Growth Fund, Inside View Investments, LLC, and KKVS Syndicate, with additional commitment to the next funding round.
About MediView
MediView is a Cleveland, OH based med-tech company working to advance human health through its digital augmented reality ecosystem. MediView’s intuitive augmented reality visualization platform aims to unlock the full potential of 3D data to transform image-guided medical procedures with intuitive 3D X-ray vision visualization, seamless remote collaboration, and evidence-based data insights. Currently, MediView is delivering these technologies through partnerships with leading organizations, including GE Healthcare and Microsoft.
To learn more, visit www.mediview.com.
